Ownership history in CITIGROUP INC · 8 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in TOURMALINE BIO INC (TRML). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 1,418 | -8,376 | -85.5% | 0.00% | $68K | — |
| 2025 Q2 | REDUCED | 9,794 | -7,218 | -42.4% | 0.00% | $157K | — |
| 2025 Q1 | REDUCED | 17,012 | -14,001 | -45.1% | 0.00% | $259K | — |
| 2024 Q4 | ADDED | 31,013 | +13,746 | +79.6% | 0.00% | $629K | — |
As of 2025 Q3 — sorted by position size